Skip to main content
SpringerLink
Log in

IgA Nephropathy and Henoch-Schönlein Purpura

  • Chapter
  • First Online:
Practical Nephrology

Abstract

Since its initial description by Jean Berger in 1968, immunoglobulin A nephropathy (IgAN) is now recognised as the commonest noninfectious form of glomerulonephritis in the world. Although in many patients it has a benign course, IgAN remains a leading cause of progressive kidney disease, with around 25–30 % of patients progressing to end-stage renal disease within 25 years of diagnosis. IgAN can only be diagnosed by renal biopsy, which is characterised by mesangial deposition of IgA.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. D’Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis. 2000;36(2):227–37.

    Article  PubMed  Google Scholar 

  2. Suzuki K, Honda K, Tanabe K, Toma H, Nihei H, Yamaguchi Y. Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int. 2003;63(6):2286–94.

    Article  PubMed  Google Scholar 

  3. Barratt J, Smith AC, Feehally J. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy. Nephrology (Carlton). 2007;12(3):275–84.

    Article  CAS  Google Scholar 

  4. Barratt J, Feehally J. Primary IgA nephropathy: new insights into pathogenesis. Semin Nephrol. 2011;31(4):349–60.

    Article  CAS  PubMed  Google Scholar 

  5. Topham PS, Harper SJ, Furness PN, Harris KP, Walls J, Feehally J. Glomerular disease as a cause of isolated microscopic haematuria. Q J Med. 1994;87(6):329–35.

    CAS  PubMed  Google Scholar 

  6. Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 2009;76(5):546–56.

    Article  PubMed  Google Scholar 

  7. Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009;76(5):534–45.

    Article  PubMed  Google Scholar 

  8. Coppo R, Troyanov S, Camilla R, Hogg RJ, Cattran DC, Cook HT, et al. The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int. 2010;77(10):921–7.

    Article  CAS  PubMed  Google Scholar 

  9. Pouria S, Barratt J. Secondary IgA nephropathy. Semin Nephrol. 2008;28(1):27–37.

    Article  PubMed  Google Scholar 

  10. Piccoli A, Codognotto M, Tabbi MG, Favaro E, Rossi B. Influence of tonsillectomy on the progression of mesangioproliferative glomerulonephritis. Nephrol Dial Transplant. 2010;25(8):2583–9.

    Article  PubMed  Google Scholar 

  11. Wang Y, Chen J, Chen Y, Wang L, Lv Y. A meta-analysis of the clinical remission rate and long-term efficacy of tonsillectomy in patients with IgA nephropathy. Nephrol Dial Transplant. 2011;26(6):1923–31.

    Article  CAS  PubMed  Google Scholar 

  12. Reich HN, Troyanov S, Scholey JW, Cattran DC. Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol. 2007;18(12):3177–83.

    Article  CAS  PubMed  Google Scholar 

  13. Coppo R, Peruzzi L, Amore A, Piccoli A, Cochat P, Stone R, et al. IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria. J Am Soc Nephrol. 2007;18:1880–8.

    Article  CAS  PubMed  Google Scholar 

  14. Praga M, Gutierrez E, Gonzalez E, Morales E, Hernandez E. Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial. J Am Soc Nephrol. 2003;14(6):1578–83.

    Article  CAS  PubMed  Google Scholar 

  15. Mann JF, Schmieder RE, McQueen M, Dyal L, Schumacher H, Pogue J, et al. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet. 2008;372(9638):547–53.

    Article  CAS  PubMed  Google Scholar 

  16. Pozzi C, Andrulli S, Del Vecchio L, Melis P, Fogazzi GB, Altieri P, et al. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J Am Soc Nephrol. 2004;15(1):157–63.

    Article  CAS  PubMed  Google Scholar 

  17. Lv J, Zhang H, Chen Y, Li G, Jiang L, Singh AK, et al. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial. Am J Kidney Dis. 2009;53(1):26–32.

    Article  CAS  PubMed  Google Scholar 

  18. Manno C, Torres DD, Rossini M, Pesce F, Schena FP. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy. Nephrol Dial Transplant. 2009;24(12):3694–701.

    Article  CAS  PubMed  Google Scholar 

  19. Eitner F, Ackermann D, Hilgers RD, Floege J. Supportive versus immunosuppressive therapy of progressive IgA nephropathy (STOP) IgAN trial: rationale and study protocol. J Nephrol. 2008;21(3):284–9.

    CAS  PubMed  Google Scholar 

  20. Donadio Jr JV, Grande JP, Bergstralh EJ, Dart RA, Larson TS, Spencer DC. The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group. J Am Soc Nephrol. 1999;10(8):1772–7.

    CAS  PubMed  Google Scholar 

  21. Strippoli GF, Manno C, Schena FP. An “evidence-based” survey of therapeutic options for IgA nephropathy: assessment and criticism. Am J Kidney Dis. 2003;41(6):1129–39.

    Article  CAS  PubMed  Google Scholar 

  22. Xu G, Tu W, Jiang D, Xu C. Mycophenolate mofetil treatment for IgA nephropathy: a meta-analysis. Am J Nephrol. 2008;29(5):362–7.

    PubMed  Google Scholar 

  23. Tang SC, Tang AW, Wong SS, Leung JC, Ho YW, Lai KN. Long-term study of mycophenolate mofetil treatment in IgA nephropathy. Kidney Int. 2010;77(6):543–9.

    Article  CAS  PubMed  Google Scholar 

  24. Tumlin JA, Hennigar RA. Clinical presentation, natural history, and treatment of crescentic proliferative IgA nephropathy. Semin Nephrol. 2004;24(3):256–68.

    Article  PubMed  Google Scholar 

  25. Lai KN, Lai FM, Ho CP, Chan KW. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial. Clin Nephrol. 1986;26(4):174–80.

    CAS  PubMed  Google Scholar 

  26. Floege J. Recurrent IgA nephropathy after renal transplantation. Semin Nephrol. 2004;24(3):287–91.

    Article  PubMed  Google Scholar 

  27. Clayton P, McDonald S, Chadban S. Steroids and recurrent IgA nephropathy after kidney transplantation. Am J Transplant. 2011;11(8):1645–9.

    Article  CAS  PubMed  Google Scholar 

  28. Courtney AE, McNamee PT, Nelson WE, Maxwell AP. Does angiotensin blockade influence graft outcome in renal transplant recipients with IgA nephropathy? Nephrol Dial Transplant. 2006;21(12):3550–4.

    Article  CAS  PubMed  Google Scholar 

  29. Davin JC, Ten Berge IJ, Weening JJ. What is the difference between IgA nephropathy and Henoch-Schonlein purpura nephritis? Kidney Int. 2001;59(3):823–34.

    Article  CAS  PubMed  Google Scholar 

  30. Sanders JT, Wyatt RJ. IgA nephropathy and Henoch-Schonlein purpura nephritis. Curr Opin Pediatr. 2008;20(2):163–70.

    Article  PubMed  Google Scholar 

  31. Saulsbury FT. Henoch-Schonlein purpura in children. Report of 100 patients and review of the literature. Medicine. 1999;78(6):395–409.

    Article  CAS  PubMed  Google Scholar 

  32. Gedalia A. Henoch-Schonlein purpura. Curr Rheumatol Rep. 2004;6(3):195–202.

    Article  PubMed  Google Scholar 

  33. Sano H, Izumida M, Shimizu H, Ogawa Y. Risk factors of renal involvement and significant proteinuria in Henoch-Schonlein purpura. Eur J Pediatr. 2002;161(4):196–201.

    Article  CAS  PubMed  Google Scholar 

  34. Ponticelli C, Glassock RJ. Posttransplant recurrence of primary glomerulonephritis. Clin J Am Soc Nephrol. 2010;5(12):2363–72.

    Article  PubMed  Google Scholar 

  35. Meulders Q, Pirson Y, Cosyns JP, Squifflet JP, van Ypersele de Strihou C. Course of Henoch-Schonlein nephritis after renal transplantation. Report on ten patients and review of the literature. Transplantation. 1994;58(11):1179–86.

    Article  CAS  PubMed  Google Scholar 

  36. Ronkainen J, Nuutinen M, Koskimies O. The adult kidney 24 years after childhood Henoch-Schonlein purpura: a retrospective cohort study. Lancet. 2002;360(9334):666–70.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The John Walls Renal Unit, Leicester General Hospital, Gwendolen Road, Leicester, LE5 4PW, UK

    Chee Kay Cheung BSc, MBChB, Joanna K. F. Boyd MBChB & Jonathan Barratt PhD, FRCP

Authors
  1. Chee Kay Cheung BSc, MBChB
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joanna K. F. Boyd MBChB
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jonathan Barratt PhD, FRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jonathan Barratt PhD, FRCP .

Editor information

Editors and Affiliations

  1. UCL Department of Nephrology, Royal Free London NHS Foundation Trust, London, United Kingdom

    Mark Harber

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Cheung, C.K., Boyd, J.K.F., Barratt, J. (2014). IgA Nephropathy and Henoch-Schönlein Purpura. In: Harber, M. (eds) Practical Nephrology. Springer, London. https://doi.org/10.1007/978-1-4471-5547-8_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-5547-8_19

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-5546-1

  • Online ISBN: 978-1-4471-5547-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation